The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 30, 2021

Filed:

Jan. 27, 2017
Applicant:

University of Southampton, Southampton, GB;

Inventor:

Ali Tavassoli, Southampton, GB;

Assignee:

UNIVERSITY OF SOUTHAMPTON, Southampton, GB;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/18 (2006.01); A61K 38/08 (2019.01); A61P 35/00 (2006.01); C07K 14/47 (2006.01); C07K 7/06 (2006.01); C07K 7/02 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6845 (2013.01); A61K 38/08 (2013.01); A61K 38/18 (2013.01); A61P 35/00 (2018.01); C07K 7/02 (2013.01); C07K 7/06 (2013.01); C07K 14/4702 (2013.01); G01N 2500/02 (2013.01);
Abstract

The present invention relates to inhibitors of HIF-1 and HIF-2 and uses thereof. The present invention further relates to the inhibitors for use in treatment of diseases. An isolated polypeptide is provided, that prevents dimerization of HIF-1α with HIF-1β and HIF-2α with HIF-1β and/or inhibits the activity of HIF-1 and HIF-2, wherein the polypeptide comprises the amino acid sequence C-X1-X2-X3-Z-X4 (SEQ ID NO 1) and wherein X1, X2, X3 and X4 are any amino acid and wherein Z is leucine, valine of isoleucine or a non-natural derivative or leucine, valine or isoleucine. The isolated polypeptide prevents dimerization of HIF-1α with HIF-1β and HIF-2α with HIF-1β and inhibits the activity of HIF-1 and HIF-2 by binding to HIF-1α or HIF-1β and/or HIF-2α or HIF-1β.


Find Patent Forward Citations

Loading…